Journal of Immunotherapy
Q1 Journal
Journal
Country
United States
Northern America
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Pharmacology
Q1
└
Cancer Research
Q2
└
Immunology
Q2
Publisher
SJR 2025
1.088
Q1
SJR Score
H-Index
111
Citations / Doc (2yr)
2.75
Total Docs. (latest)
45
Total Citations (3yr)
426
Publication type
Journals
ISSN
15249557, 15374513
Coverage
1991-2026
Journal Rank
#4,255
Subject Categories
Pharmacology
Q1
Cancer Research
Q2
Immunology
Q2
Immunology and Allergy
Q2
Subject Areas
Aims & Scope
Journal of Immunotherapy features rapid publication of articles on immunomodulators, lymphokines, antibodies, cells, and cell products in cancer biology and therapy.
Laboratory and preclinical studies, as well as investigative clinical reports, are presented.
The journal emphasizes basic mechanisms and methods for the rapid transfer of technology from the laboratory to the clinic.
JIT contains full-length articles, review articles, and short communications.
Abstracting & Indexing
Scopus
Google Scholar
Web of Science
Medline
Embase
Detailed Metrics
| Total Docs. (latest) | 45 |
| Total Docs. (3 years) | 145 |
| Total Refs. | 1,740 |
| Total Citations (3 years) | 426 |
| Citable Docs. (3 years) | 145 |
| Citations / Doc. (2 years) | 2.75 |
| Ref. / Doc. | 38.67 |
| % Female | 40.6% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.